| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
More than 100 companies are developing or have developed antibody array and/or
bead platforms. The competition is fierce, but the progress in the field has
been slow. The problem has been a disconnect between the capabilities of the
available technologies and the demands of the market place.
This analysis goes right to the demands of the marketplace, identifying and
analyzing current and future practices, unmet needs, and opportunities and
challenges. It provides key information for companies to optimize their
strategies to take advantage of the large opportunities and avoid the major
pitfalls.
D&MD's Market Opportunities and Challenges for Antibody Arrays and Beads
answers crucial questions such as:
- What antibody arrays and beads are currently in use?
- What are the strengths and weaknesses of these platforms?
- How do arrays compare with beads?
- What is the impact of the content problem?
- What are the preferred formats?
Data for this proprietary market research study was obtained through detailed
interviews with users in order to characterize opportunities and challenges,
trends, current practices and unmet needs. In addition to the interviews, an
online quantitative survey was conducted to provide metrics for opportunities
and challenges in this space. All research and analysis was conducted by an
expert in the field.
TABLE OF CONTENTS
Chapter 1: Executive Summary
Chapter 2: Introduction to Antibody Arrays and Beads
- Description
- Using Antibody Arrays and Beads
- Antibodies and Alternative Capture Agents
- Detection
- Applications
Chapter 3: Market Research Methodology
- Interview Analysis
- Strengths and Weaknesses
- Planar Arrays versus Beads
- Content
- New Detection Methods
- Survey Analysis
Chapter 4: Market Model
Chapter 5: Contact Reports
- Abbott Laboratories
- Altana Pharma
- Amgen
- Antigenetics
- Dynavax Technologies
- Eli Lilly
- German Cancer Research Center
- Inhibitex
- MedImmune Vaccines
- Specialty Laboratories
- Strategic Diagnostics
- University of Tuebingen
- Van Andel Institute
|
